Issue

Vol. 30 No. 4 (2018): Vol 30 Issue 4

Copyright (c) 2018 AJC

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Stability Indicating Reverse Phase High Performance Liquid Chromatographic Method with Photodiode Array Detection for the Simultaneous Quantification of Quinapril and Hydrochlorthiazide in Bulk and Tablet Dosage Forms

https://doi.org/10.14233/ajchem.2018.21118
K. Lakshmi Prameela
Department of Chemistry, YA Government Degree College for Women, Chirala-523 155, India 2Department of Chemistry, Acharya Nagarjuna University, Nagarjuna nagar, Guntur-522 510, India
P. Rama Krishna Veni
Department of Applied Sciences and Humanities, Sasi Institute of Technology & Engineering, Tadepalligudem-534 101, India
P.V.V. Satyanarayana
Department of Chemistry, Acharya Nagarjuna University, Nagarjuna nagar, Guntur-522 510, India
B. Hari Babu
Department of Chemistry, Acharya Nagarjuna University, Nagarjuna nagar, Guntur-522 510, India

Corresponding Author(s) : B. Hari Babu

drharibabuanu2015@gmail.com; dr.b.haribabu@gmail.com

Asian Journal of Chemistry, Vol. 30 No. 4 (2018): Vol 30 Issue 4

Abstract

The combination of hydrochlorothiazide and quinapril is used to treat high blood pressure. In the current study, a stability-indicating RP-HPLC method with photodiode array detection was developed and validated for the simultaneous determination of quinapril and hydrochlorthiazide in bulk and tablet dosage form. Separation and analysis of selected drug combination in the presence of degradation products was achieved on Agilent C18 (250 mm × 4.6 mm, 5 μ) column. A mixture of 0.1 M KH2PO4 and methanol (65:35, v/v) was used as mobile phase. The developed method was linear over the concentration range of 10-30 μg/mL (quinapril) and 6.25-18.75 μg/mL (hydrochlorothiazide) with acceptable precision and accuracy. The degradation studies showed that quinapril and hydrochlorthiazide are relatively unstable under acidic, basic, oxidative, thermal and photo degradation conditions applied. No interference peaks from common tablet excipients and degradation products were observed. The proposed stability-indicating RP-HPLC method could be opt for routine quality control studies of quinapril and hydrochlorthiazide combined dosage forms.

Keywords

HPLC Quinapril Hydrochlorthiazide Stability indicating Forced degradation
Prameela, K. L., Krishna Veni, P. R., Satyanarayana, P., & Babu, B. H. (2018). Stability Indicating Reverse Phase High Performance Liquid Chromatographic Method with Photodiode Array Detection for the Simultaneous Quantification of Quinapril and Hydrochlorthiazide in Bulk and Tablet Dosage Forms. Asian Journal of Chemistry, 30(4), 873–878. https://doi.org/10.14233/ajchem.2018.21118
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. G.M. Keating, Drugs, 69, 1239 (2009); https://doi.org/10.2165/00003495-200969090-00008.
  2. A.Z., LaCroix, S.M. Ott, L. Ichikawa, D. Scholes and W.E. Barlow, Ann. Intern. Med., 133, 516 (2000); https://doi.org/10.7326/0003-4819-133-7-200010030-00010.
  3. J. Loffing, J. Am. Soc. Nephrol., 15, 2948 (2004); https://doi.org/10.1097/01.ASN.0000146568.82353.04.
  4. F.H. Messerli, H. Makani, A. Benjo, J. Romero, C. Alviar and S. Bangalore, J. Am. Coll. Cardiol., 57, 590 (2011); https://doi.org/10.1016/j.jacc.2010.07.053.
  5. C.R. Culy and B. Jarvis, Drugs, 62, 339 (2002); https://doi.org/10.2165/00003495-200262020-00009.
  6. G. Gambini, G. Pinchi and C. Valori, Recenti. Prog. Med., 90, 654 (1999).
  7. A. Owada, H. Nonoguchi, Y. Terada, F. Marumo and K. Tomita, Clin. Exp. Hypertens., 19, 495 (1997); .
  8. I.V., Radevski, Z.P. Valtchanova, G.P. Candy, M.N. Hlatswayo and P. Sareli, J. Clin. Pharmacol., 40, 713 (2000); https://doi.org/10.1177/00912700022009468.
  9. D. Kowalczuk and H. Hopkala, J. AOAC Int., 87, 847 (2004).
  10. E. Dinç, S. Altinöz and D. Baleanu, Rev. Chim. (Bucureti), 58, 1263 (2007).
  11. E. Dinç and D. Baleanu, J. Braz. Chem. Soc., 18, 962 (2007); https://doi.org/10.1590/S0103-50532007000500013.
  12. T.G. Vandana, P.B. Miniyar, D.D. Bhandari, M.K. Ghag, D.B. Rajput and A.A. Mahajan, Asian J. Chem., 26, 3799 (2014); https://doi.org/10.14233/ajchem.2014.15935.
  13. V.A. Chatpalliwar, D.D. Patil, S.J. Surana and G.B. Bhavar, Indian J. Pharm. Sci., 70, 529 (2008); https://doi.org/10.4103/0250-474X.44612.
  14. S.A. Parekh, A. Pudage, S.S. Joshi, V.V. Vaidya, N.A. Gomes and S.S. Kamat, J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci., 873, 59 (2008); https://doi.org/10.1016/j.jchromb.2008.07.046.
  15. H. Kanchukommula, A.T. Subramaniam, J. Munusamy, K. Danapal and S. Sengodan, J. Pharma. Chem., 1, 10 (2014); https://doi.org/10.14805/jphchem.2014.art8.
  16. G.S. Rani, B.M. Gandhi, G.M. Kumar, M. Rekha, K.P. Raju and N. Manjusha, World J. Pharm. Pharma. Sci., 2, 6220 (2013).
  17. G. Srikanth, M.A. Haque, D. Sireesha, V. Bakshi and S. Harshini, Int. J. Inno. Pharma. Sci. Res., 2, 2757 (2014).
  18. S. Altunsoy, B. Bozal-Palabiyik and B. Uslu, Turk. J. Pharm. Sci., 10, 255 (2013).
  19. K.G. Rao, K.M. Devi and M. Pavani, World J. Pharma Res., 5, 1295 (2016).
  20. M. Gandhimathi and T.K. Ravi, Indian J. Pharm. Sci., 71, 311 (2009); https://doi.org/10.4103/0250-474X.56035.
  21. T.A. Shabeen and S. Rubesh kumar, Int. J. Sci. Res., 3, 1134 (2014).
  22. M. de Diego, S. Mennickent, J. Muñoz, F. Sanhueza and R. Godoy, Cent. Eur. J. Chem., 12, 470 (2014); https://doi.org/10.2478/s11532-013-0396-z.
  23. International Conference on the Harmonization, ICH Harmonized Tripartite Guideline, Stability Testing of New Drug Substances and Products Q1A (R2), November (2003).
  24. International Conference on the Harmonization, ICH Harmonized Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2 (R1), November (2005).
Read More
Author biographies is not available.
Download
PDF
Statistic
Read Counter : 0 Download : 0